Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimensXiao Liu, Guangxun Gao, Shuangshuang Jia et al.|Frontiers in Oncology|2022Cited by 10